0001628280-22-016875.txt : 20220610 0001628280-22-016875.hdr.sgml : 20220610 20220610172641 ACCESSION NUMBER: 0001628280-22-016875 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220608 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schobel Alexander Mark CENTRAL INDEX KEY: 0001406836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 221009983 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 wf-form4_165489638239475.xml FORM 4 X0306 4 2022-06-08 0 0001398733 Aquestive Therapeutics, Inc. AQST 0001406836 Schobel Alexander Mark C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE WARREN NJ 07059 0 1 0 0 Chief Innovation/Tech Officer Common Stock 2022-06-08 4 P 0 45871 0.96 A 882871 D Warrant (Right to Buy) 0.96 2022-06-08 4 P 0 45871 0.13 A 2022-12-08 2027-06-08 Common Stock 45871.0 45871 D Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13. /s/ Lori J. Braender, as Attorney-in-Fact 2022-06-10